Colgate-Palmolive Company (CL)
FMCG giants Nestle, P&G, Colgate have lost their shine: what next
The consumer goods giants that built empires on household staples are struggling to justify their valuations. At the time of writing, Nestlé has shed nearly a quarter of its market value over the past five years.
Colgate's Q1 Earnings Upcoming: Here's What Investors Should Know
CL eyes Q1 growth with rising sales and EPS, but cost pressures and weak volumes may limit upside despite innovation and premium push.
Colgate-Palmolive Company $CL Shares Bought by Caprock Group LLC
Caprock Group LLC raised its stake in Colgate-Palmolive Company (NYSE: CL) by 116.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,808 shares of the company's stock after acquiring an additional 34,879 shares during the period. Caprock Group LLC's
Boston Trust Walden Corp Raises Position in Colgate-Palmolive Company $CL
Boston Trust Walden Corp grew its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 4.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 170,118 shares of the company's stock after purchasing an additional 7,434 shares during the quarter.
Cwm LLC Has $3.58 Million Holdings in Colgate-Palmolive Company $CL
Cwm LLC grew its position in shares of Colgate-Palmolive Company (NYSE: CL) by 20.3% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 45,345 shares of the company's stock after purchasing an additional 7,665 shares during the quarter. Cwm LLC's holdings in
Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble vs. Colgate: Which Dividend Stock Rules Them All
Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) reported quarterly earnings in January, placing two of consumer staples' most decorated dividend payers in sharp contrast.
Tariffs and Costs: How Exposed Is Colgate's 2026 Margin Outlook?
CL braces for tariff volatility into 2026, leaning on supply-chain shifts, pricing discipline and productivity gains to defend margins.
Colgate's Pet Nutrition Strength: Can Hill's Sustain Momentum?
CL's Hill's Pet Nutrition outperforms a soft market as prescription diets, cat growth and science-led innovation drove share gains and sustained momentum.
High Oil Prices Will Hurt Colgate-Palmolive Stock According to Wall Street
Colgate-Palmolive (NYSE:CL) lost a key Wall Street backer on Tuesday as TD Cowen analyst Robert Moskow downgraded the stock from Buy to Hold and cut his price target to $85 from $96, citing surging oil-based input costs tied to the Iran War.
Colgate must face lawsuits over safety of mouth rinse for young children
A federal judge on Friday said Colgate-Palmolive must face two lawsuits claiming its packaging for mouth rinse misleads parents into believing children under 6 can use the products safely. The judge dismissed a similar lawsuit concerning Colgate toothpaste.
Top Stock Picks of 2026: Colgate-Palmolive
For the final few weeks of the first quarter we're going to highlight one of Schaeffer's top 15 picks for 2026.
